InspireMD, Inc.

NASDAQ:NSPR

2.27 (USD) • At close June 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018201720162015201420132012201120102009
Revenue 7.0096.2055.1714.4952.4853.7213.6012.7611.8942.312.8184.8735.3496.00403.411
Cost of Revenue 5.5034.3984.0543.7412.4022.9652.6062.1761.7922.6062.0342.2832.8493.01100
Gross Profit 1.5061.8071.1170.7540.0830.7560.9950.5850.102-0.2960.7842.592.52.99300
Gross Profit Ratio 0.2150.2910.2160.1680.0330.2030.2760.2120.054-0.1280.2780.5320.4670.49900
Reseach & Development Expenses 13.6347.9817.815.1582.2332.9541.5351.2761.2913.6428.7444.1563.9882.47400
General & Administrative Expenses 15.30611.1048.3567.4056.1275.2224.835.18456.3879.1258.97313.88312.2750.0150.004
Selling & Marketing Expenses 6.0693.8653.6642.9072.1032.3962.2412.3571.4593.1786.6133.6162.1741.97300
SG&A 21.37514.96912.0210.3128.237.6187.0717.5416.4599.56515.73812.58916.05714.2480.0150.004
Other Expenses 000000000000.9180000
Operating Expenses 35.00922.9519.8315.4710.46310.5728.6068.8177.7513.20724.48217.66320.04516.7220.0150.004
Operating Income -33.503-21.143-18.713-14.716-10.38-9.816-7.611-8.232-7.648-14.485-23.698-15.073-17.545-13.729-0.015-0.004
Operating Income Ratio -4.78-3.407-3.619-3.274-4.177-2.638-2.114-2.982-4.038-6.271-8.41-3.093-3.28-2.2870-0.001
Total Other Income Expenses Net 1.5571.2920.25-0.157-0.16-0.20.371-0.179-0.812-1.096-1.385-14.177-0.038-0.934-0.1540.04
Income Before Tax -31.946-19.851-18.463-14.873-10.54-10.016-7.24-8.411-8.46-15.581-25.083-29.25-17.583-14.663-3.373-2.677
Income Before Tax Ratio -4.558-3.199-3.57-3.309-4.241-2.692-2.011-3.046-4.467-6.745-8.901-6.002-3.287-2.4420-0.785
Income Tax Expense 0.0590.0650.0280.0450.0040.024-0.3710.0270.0010.0040.0120.0080.0140.0020.0240.004
Net Income -32.005-19.916-18.491-14.918-10.544-10.04-7.24-8.438-8.461-15.585-25.095-29.258-17.597-14.665-0.024-0.004
Net Income Ratio -4.566-3.21-3.576-3.319-4.243-2.698-2.011-3.056-4.467-6.747-8.905-6.004-3.29-2.4430-0.001
EPS -0.76-0.82-2.35-2.03-6.97-72-247.5-4,265.93-151,089.29-1,416,818.18-4,182,500-5,851,600-9,217.92-7,332,500-3,425.14-956.25
EPS Diluted -0.76-0.82-2.35-2.03-6.97-72-247.5-4,265.93-151,089.29-1,416,818.18-4,182,500-5,851,600-9,217.92-7,332,500-3,425.14-956.25
EBITDA -33.223-20.911-18.525-14.555-10.229-9.658-7.459-8.114-7.548-14.244-23.411-14.865-16.225-13.342-3.177-2.367
EBITDA Ratio -4.74-3.37-3.582-3.238-4.116-2.596-2.071-2.939-3.985-6.166-8.308-3.05-3.033-2.2220-0.694